87
63
Growth Score
0 pts
Heat Score
12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
335285
NeuBio specializes in precision diagnostics and AI-driven drug development for CNS diseases.
- Jonathan Zamir: Co-Founder
Patrick Lilley: Co-Founder & Board Member
About the Company
NeuBio is a biotechnology company focused on advancing precision diagnostics and drug development for central nervous system (CNS) diseases. Utilizing innovative AI technology, NeuBio aims to identify biological markers involved in neurological conditions such as Parkinson's Disease and Alzheimer's. The company offers a range of
diagnostic testing from a single blood sample, enhancing the understanding and treatment of CNS disorders. NeuBio is also developing personalized education and rehabilitation programs through its app, targeting improvements in speech and hearing abilities. With a commitment to accelerating the path to recovery for patients, NeuBio stands at the forefront of neurobiology research and application.
